|
|
Found results for
 patents
1.
|
COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
| Application Number |
US2024026187 |
| Publication Number |
2024/226736 |
| Status |
In Force |
| Filing Date |
2024-04-25 |
| Publication Date |
2024-10-31 |
| Owner |
- ACHIEVE LIFE SCIENCES, INC. (USA)
- ACHIEVE PHARMA UK LIMITED (United Kingdom)
|
| Inventor |
- Jacobs, Cindy A.
- Cain, Daniel F.
- Clarke, Anthony
|
Abstract
Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
IPC Classes ?
- A61K 31/4162 - 1,2-Diazoles condensed with heterocyclic ring systems
- A61K 31/439 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- C07D 471/04 - Ortho-condensed systems
- A61P 25/34 - Tobacco-abuse
|
2.
|
COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
| Application Number |
US2020046308 |
| Publication Number |
2021/050203 |
| Status |
In Force |
| Filing Date |
2020-08-14 |
| Publication Date |
2021-03-18 |
| Owner |
- ACHIEVE LIFE SCIENCES, INC. (USA)
- ACHIEVE PHARMA UK LIMITED (United Kingdom)
|
| Inventor |
- Jacobs, Cindy, A.
- Cain, Daniel, F.
- Clarke, Anthony
|
Abstract
Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
IPC Classes ?
- A24B 15/16 - Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A61K 31/465 - NicotineDerivatives thereof
- A61K 9/00 - Medicinal preparations characterised by special physical form
|
3.
|
CYTISINE SALTS
| Application Number |
GB2018052085 |
| Publication Number |
2019/020993 |
| Status |
In Force |
| Filing Date |
2018-07-24 |
| Publication Date |
2019-01-31 |
| Owner |
ACHIEVE PHARMA UK LIMITED (United Kingdom)
|
| Inventor |
- Clarke, Anthony
- Stewart, Richard Alistair Balfour
|
Abstract
Salts of cytisine have been prepared and incorporated in stable pharmaceutical compositions, including compositions comprising lactose. The salts are prepared by adding acid stock solutions to solutions of cytisine with heating, followed by cooling to ambient temperature. The salts and compositions are indicated in the treatment of nicotine addiction.
IPC Classes ?
- C07D 471/18 - Bridged systems
- A61P 25/34 - Tobacco-abuse
- A61K 31/439 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
|
4.
|
SUCCINATE SALT OF CYTISINE AND USE THEREOF
| Application Number |
GB2017050294 |
| Publication Number |
2017/134468 |
| Status |
In Force |
| Filing Date |
2017-02-06 |
| Publication Date |
2017-08-10 |
| Owner |
ACHIEVE PHARMA UK LIMITED (United Kingdom)
|
| Inventor |
- Clarke, Anthony
- Stewart, Richard Allistair
- Willis, Andrew Gareth
|
Abstract
The invention relates to a novel salt of cytisine and pharmaceutical compositions comprising that salt. In particular, the invention relates to a succinate salt of cytisine which displays improved excipient compatibility, permitting the preparation of stable pharmaceutical compositions.
IPC Classes ?
- A61K 31/439 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A61P 25/34 - Tobacco-abuse
|
|
